Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study

BACKGROUND: To assess the feasibility and early toxicity of selective, IMRT-based dose escalation (simultaneous integrated boost) to biopsy proven dominant intra-prostatic lesions visible on MRI. METHODS: Patients with localized prostate cancer and an abnormality within the prostate on endorectal co...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Anurag K, Guion, Peter, Sears-Crouse, Nancy, Ullman, Karen, Smith, Sharon, Albert, Paul S, Fichtinger, Gabor, Choyke, Peter L, Xu, Sheng, Kruecker, Jochen, Wood, Bradford J, Krieger, Axel, Ning, Holly
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075521/
https://www.ncbi.nlm.nih.gov/pubmed/17877821
http://dx.doi.org/10.1186/1748-717X-2-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075521/
https://www.ncbi.nlm.nih.gov/pubmed/17877821
http://dx.doi.org/10.1186/1748-717X-2-36

Ejemplares similares